Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

832 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
Moya FR, Gadzinowski J, Bancalari E, Salinas V, Kopelman B, Bancalari A, Kornacka MK, Merritt TA, Segal R, Schaber CJ, Tsai H, Massaro J, d'Agostino R; International Surfaxin Collaborative Study Group. Moya FR, et al. Among authors: segal r. Pediatrics. 2005 Apr;115(4):1018-29. doi: 10.1542/peds.2004-2183. Pediatrics. 2005. PMID: 15805380 Clinical Trial.
A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, Wiswell TE, Gadzinowski J, Hajdu J, Bernstein G, Sanchez-Luna M, Segal R, Schaber CJ, Massaro J, d'Agostino R; Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group. Sinha SK, et al. Among authors: segal r. Pediatrics. 2005 Apr;115(4):1030-8. doi: 10.1542/peds.2004-2231. Pediatrics. 2005. PMID: 15805381 Clinical Trial.
One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
Moya F, Sinha S, Gadzinowski J, D'Agostino R, Segal R, Guardia C, Mazela J, Liu G; SELECT and STAR Study Investigators. Moya F, et al. Among authors: segal r. Pediatrics. 2007 Jun;119(6):e1361-70. doi: 10.1542/peds.2006-0149. Epub 2007 May 28. Pediatrics. 2007. PMID: 17533176 Clinical Trial.
A pilot, randomized, controlled clinical trial of lucinactant, a peptide-containing synthetic surfactant, in infants with acute hypoxemic respiratory failure.
Thomas NJ, Guardia CG, Moya FR, Cheifetz IM, Markovitz B, Cruces P, Barton P, Segal R, Simmons P, Randolph AG; PALISI Network. Thomas NJ, et al. Among authors: segal r. Pediatr Crit Care Med. 2012 Nov;13(6):646-53. doi: 10.1097/PCC.0b013e3182517bec. Pediatr Crit Care Med. 2012. PMID: 22791092 Clinical Trial.
Prospective observational study of early respiratory management in preterm neonates less than 35 weeks of gestation.
Moya FR, Mazela J, Shore PM, Simonson SG, Segal R, Simmons PD, Gregory TJ, Guardia CG, Varga JR, Finer NN; Preterm Neonate Early Respiratory Management Prospective Observational Study investigators. Moya FR, et al. Among authors: segal r. BMC Pediatr. 2019 May 11;19(1):147. doi: 10.1186/s12887-019-1518-3. BMC Pediatr. 2019. PMID: 31078143 Free PMC article.
Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo-controlled trial.
Carubelli V, Zhang Y, Metra M, Lombardi C, Felker GM, Filippatos G, O'Connor CM, Teerlink JR, Simmons P, Segal R, Malfatto G, La Rovere MT, Li D, Han X, Yuan Z, Yao Y, Li B, Lau LF, Bianchi G, Zhang J; Istaroxime ADHF Trial Group. Carubelli V, et al. Among authors: segal r. Eur J Heart Fail. 2020 Sep;22(9):1684-1693. doi: 10.1002/ejhf.1743. Epub 2020 Jan 23. Eur J Heart Fail. 2020. PMID: 31975496 Free article. Clinical Trial.
832 results